Sulong, Rita S.
HRN: 14-44-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2025
CIPROFLOXACIN 500MG (TAB)
04/25/2025
05/01/2025
ORAL
500mg
OD
ACS-STEMI
Waiting Final Action
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes